Option chain shows key data for Biolase Inc COM PAR $.001 NEW's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Biolase Inc COM PAR $.001 NEW.

Biolase Inc COM PAR $.001 NEW (OTC:BIOL) Stock, Option Chain

Biolase

alibaba_logo

News

Intraday Update

Markets

Movers

AGYS

AKYA

AUGX

BABA

BETR

BIOL

BYND

CLOV

CTNT

DCTH

DWSN

EAST

FENC

FFIE

FOSL

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

HROW

INVO

JAMF

Maxeon Solar Technologies, Ltd. - Ordinary Shares

MAXN

MBIN

NOTV

NOVA

ONON

PLUG

PSFE

RENT

SCPX

SHIM

SMRT

Sony Group Corporation American Depositary Shares

SONY

SPCE

SPWR

STNE

SYRA

TLRY

UXIN

VUZI

WOOF

WULF

Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday&#39;s Mid-Day Session

xr:d:DAFinCU7viM:2,j:4467771911,t:23051112

Pre-Market Outlook

Trading Ideas

APDN

WRNT

Why Alcon Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket

Penny Stocks

Small Cap

ABTS

ALAB

AMTX

ANNX

ATER

BACK

BCAN

BNAI

BTDR

CUTR

CZOO

DNTH

EGOX

FRSX

GRDI

GRFS

GTBP

ISPR

JOAN

LAAC

LICY

LULU

LXEH

MRNO

NKTX

NVFY

OCGN

OTLK

RETO

SINT

SLNA

SMLP

TROO

YTEN

Shares of  Cutera, Inc. (NASDAQ: CUTR) fell sharply during Friday’s session after the company reported worse-than-expected fourth quarter adjusted EPS results.

Why Cutera Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Friday&#39;s Mid-Day Session

Biolase Inc COM PAR $.001 NEW

Biolase Inc

BioLargo Inc

BioLife Solutions Inc

BIOLIGHT LIFE SCIENCE LTD by BioLight Life Sciences Ltd.

BioLight Life Sciences Ltd

BioLineRx Ltd. - American Depositary Shares

BioLine Rx Ltd

BIOLIFE SCIENCES INC by BIOLIFE SCIENCES INC.

Biolife Sciences Inc

Press Releases

BIOLASE to Report Fourth Quarter and Full Year 2023 Results on March 21, 2024

Earnings

Biolase Reports Full-Year 2023 Results; Expects Continued Revenue Growth In 2024

Opinion

Thinking about buying stock in Xpeng, Ocugen, Quantum Computing, CONSERVATIVE BROADCAST MEDIA JOURNALISM, or BIOLASE?

Thinking about buying stock in Cardiff Oncology, BIOLASE, Akebia Therapeutics, Astera Labs, or Atossa Therapeutics?

BIOLASE to Report First Quarter 2024 Results on May 13, 2024

Biolase Reports 2024 First Quarter Results; Reiterates Full-Year 2024 Guidance For Revenue Growth and Profitability

Legal

BIOLASE Announces Delisting from Nasdaq

SWK Holdings Highlights Recent Achievements and Provides Portfolio Update

BIOLASE Reports 2024 Second Quarter Results; Achieves 40% Gross Margin as Global Consumable Sales Strengthen

Comments

Biolase Inc COM PAR $.001 NEW

Biolase Inc COM PAR $.001 NEW (BIOL) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga